[1]
2023. A Pilot Study, to Evaluate the Safety and Efficacy of Topically Applied Onabotulinum Toxin A Delivered through a Novel Iontophoresis Device in Subjects with Axillary Hyperhidrosis. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s199. DOI:https://doi.org/10.25251/skin.7.supp.199.